Alternativas terapéuticas de osteonecrosis maxilar asociada a medicamentos (ONMAM) reportes de dos casos clínicos y revisión de la literatura

INTRODUCTION: Drug-associated Maxillary Osteonecrosis is one of the most relevant adverse effects in treatment with antiresorptive drugs such as bisphosphonates and denosumab. Oncological conditions such as multiple myeloma, breast cancer, prostate, and bone-metabolic disorders such as osteoporosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardi, Nicolás, Gilligan, Gerardo, Piemonte, Eduardo, Panico, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad Nacional de Córdoba 2022
Materias:
Casos Clínicos
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987302/
https://www.ncbi.nlm.nih.gov/pubmed/36542580
http://dx.doi.org/10.31053/1853.0605.v79.n4.37289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987302/
https://www.ncbi.nlm.nih.gov/pubmed/36542580
http://dx.doi.org/10.31053/1853.0605.v79.n4.37289

Ejemplares similares